XML 27 R9.htm IDEA: XBRL DOCUMENT v2.4.0.6
Income per Common Share
9 Months Ended
Mar. 29, 2013
Earnings Per Share [Abstract]  
Income per Common Share

3. Income per Common Share

The Company computes basic income per common share using net income and the weighted average number of common shares outstanding during the period. Diluted income per common share is computed using net income and the weighted average number of common shares and potentially dilutive common shares outstanding during the period. Potentially dilutive common shares include certain dilutive outstanding employee stock options, rights to purchase shares of common stock under the Company’s Employee Stock Purchase Plan (“ESPP”) and restricted stock unit awards (“RSUs”).

 

The following table illustrates the computation of basic and diluted income per common share (in millions, except per share data):

 

     Three Months Ended      Nine Months Ended  
     Mar. 29,
2013
     Mar. 30,
2012
     Mar. 29,
2013
     Mar. 30,
2012
 

Net income

   $ 391       $ 483       $ 1,245       $ 867   
  

 

 

    

 

 

    

 

 

    

 

 

 

Weighted average shares outstanding:

           

Basic

     239         241         242         236   

Employee stock options and other

     6         5         6         4   
  

 

 

    

 

 

    

 

 

    

 

 

 

Diluted

     245         246         248         240   
  

 

 

    

 

 

    

 

 

    

 

 

 

Income per common share:

           

Basic

   $ 1.64       $ 2.00       $ 5.14       $ 3.67   
  

 

 

    

 

 

    

 

 

    

 

 

 

Diluted

   $ 1.60       $ 1.96       $ 5.02       $ 3.61   
  

 

 

    

 

 

    

 

 

    

 

 

 

Anti-dilutive potential common shares excluded*

     4         3         3         5   
  

 

 

    

 

 

    

 

 

    

 

 

 

 

* For purposes of computing diluted income per common share, certain potentially dilutive securities have been excluded from the calculation because their effect would have been anti-dilutive.